mten-logo.png
Mingteng International Corporation Inc. Announces Closing of Initial Public Offering
April 22, 2024 18:30 ET | Mingteng International Corporation Inc.
Wuxi, China, April 22, 2024 (GLOBE NEWSWIRE) -- Mingteng International Corporation Inc. (the “Company” or “Mingteng International”) (Nasdaq: MTEN), an automotive mold developer and supplier in...
TCBI Logo.jpg
Texas Capital Bancshares, Inc. Announces Quarterly Dividend for Preferred Stock
April 22, 2024 18:30 ET | Texas Capital Bancshares, Inc.
DALLAS, April 22, 2024 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, and its board of directors declared a cash dividend of $14.375 per...
FGB-BLUE-LOGO_FDIC.png
First Guaranty Bank Bridgeport, WV Branch Officially Opens
April 22, 2024 18:00 ET | First Guaranty Bank
HAMMOND, La., April 22, 2024 (GLOBE NEWSWIRE) -- The First Guaranty Bank Bridgeport, West Virginia branch is officially open in its new location at 1000 Jerry Dove Dr in the Market Place business...
logo_inc.png
Saia Expands Network in New Jersey and Utah
April 22, 2024 17:56 ET | Saia, Inc.
JOHNS CREEK, Ga., April 22, 2024 (GLOBE NEWSWIRE) -- Saia Inc. (NASDAQ: SAIA) announced that Saia LTL Freight will open two new terminals today, one near Trenton, New Jersey, and another in St....
Regeneron Logo.jpg
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
April 22, 2024 17:54 ET | Regeneron Pharmaceuticals, Inc.
Oral presentations include updated results from clinical study of otoferlin gene therapy DB-OTO demonstrating restoration in children with profound genetic hearing loss Additional presentations...
gbio-logo .png
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
April 22, 2024 17:31 ET | Generation Bio Co.
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today...
Cidara.png
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
April 22, 2024 17:10 ET | Cidara Therapeutics, Inc.
SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate...
Cidara.png
Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice
April 22, 2024 17:06 ET | Cidara Therapeutics, Inc.
SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate...
tscan-logo.png
TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
April 22, 2024 17:01 ET | TScan Therapeutics, Inc.
WALTHAM, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered...
Logo for Press Releases.JPG
First Bank Announces First Quarter 2024 Net Income of $12.5 Million
April 22, 2024 16:37 ET | First Bank
HAMILTON, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- First Bank (Nasdaq Global Market: FRBA) (the Bank) today announced results for the first quarter of 2024. Net income for the first quarter of 2024...